Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
QNova Capital is a venture capital firm based in the United States, dedicated to supporting founders in the biotech and medtech sectors. The firm focuses on accelerating innovation and growth in life sciences, leveraging a history of successful drug and device approvals. Their investment strategy is informed by extensive experience in regulatory strategy and product development.
QNova Capital invests in medical devices, therapeutics, and diagnostics, particularly in oncology, infectious disease, metabolic health, and personal health. They emphasize Class 2 devices and aim to reduce the time, cost, and risk associated with FDA approval processes. Investments typically occur at the Seed, Series A, and Series B stages.
Yes, QNova Capital often leads investment rounds, particularly in early-stage biotech and medtech companies.
The firm is open to follow-on investments, especially for companies that demonstrate significant progress and alignment with their investment thesis.
Specific details about the size of QNova Capital's current fund are not publicly available.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.